Utique Enterprises Ltd
BSE:500014
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Utique Enterprises Ltd
BSE:500014
|
IN |
|
L
|
Lake Resources NL
OTC:LLKKF
|
AU |
|
IRLAB Therapeutics AB
STO:IRLAB A
|
SE |
Balance Sheet
Balance Sheet Decomposition
Utique Enterprises Ltd
Utique Enterprises Ltd
Balance Sheet
Utique Enterprises Ltd
| Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
2
|
1
|
0
|
1
|
1
|
1
|
185
|
190
|
196
|
205
|
208
|
1
|
5
|
249
|
282
|
36
|
126
|
170
|
121
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
5
|
249
|
282
|
36
|
126
|
170
|
121
|
|
| Cash Equivalents |
2
|
1
|
0
|
1
|
1
|
1
|
185
|
190
|
196
|
205
|
208
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
100
|
100
|
38
|
61
|
0
|
0
|
0
|
0
|
0
|
214
|
211
|
0
|
0
|
0
|
0
|
0
|
155
|
|
| Total Receivables |
200
|
199
|
310
|
120
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
51
|
192
|
164
|
61
|
|
| Accounts Receivables |
174
|
174
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
51
|
0
|
0
|
0
|
|
| Other Receivables |
26
|
25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
192
|
0
|
0
|
|
| Inventory |
32
|
32
|
32
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
0
|
0
|
0
|
0
|
153
|
170
|
167
|
194
|
|
| Other Current Assets |
0
|
8
|
9
|
10
|
123
|
124
|
9
|
9
|
10
|
11
|
11
|
8
|
9
|
9
|
10
|
217
|
20
|
17
|
19
|
|
| Total Current Assets |
234
|
241
|
451
|
256
|
191
|
216
|
218
|
223
|
231
|
241
|
244
|
223
|
224
|
259
|
297
|
457
|
509
|
518
|
550
|
|
| PP&E Net |
2 460
|
2 457
|
73
|
70
|
65
|
63
|
62
|
60
|
56
|
55
|
53
|
51
|
50
|
47
|
44
|
5
|
8
|
14
|
10
|
|
| PP&E Gross |
2 460
|
2 457
|
73
|
70
|
65
|
63
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
56
|
58
|
61
|
62
|
61
|
63
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Long-Term Investments |
143
|
143
|
142
|
111
|
127
|
107
|
107
|
107
|
107
|
107
|
107
|
63
|
63
|
62
|
9
|
8
|
141
|
152
|
114
|
|
| Other Long-Term Assets |
2 355
|
2 397
|
1 571
|
1 483
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
43
|
36
|
34
|
|
| Total Assets |
5 192
N/A
|
5 238
+1%
|
2 237
-57%
|
1 920
-14%
|
383
-80%
|
385
+1%
|
387
+0%
|
390
+1%
|
394
+1%
|
402
+2%
|
403
+0%
|
337
-17%
|
336
0%
|
367
+9%
|
350
-5%
|
469
+34%
|
701
+49%
|
720
+3%
|
712
-1%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
0
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
| Other Current Liabilities |
499
|
499
|
433
|
232
|
15
|
16
|
11
|
9
|
10
|
10
|
11
|
10
|
9
|
10
|
17
|
13
|
11
|
11
|
3
|
|
| Total Current Liabilities |
499
|
504
|
438
|
232
|
15
|
16
|
11
|
9
|
10
|
11
|
11
|
11
|
10
|
11
|
17
|
13
|
13
|
13
|
5
|
|
| Long-Term Debt |
2 989
|
3 510
|
211
|
100
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
10
|
7
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
214
|
214
|
222
|
223
|
223
|
223
|
223
|
154
|
154
|
154
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3 488
N/A
|
4 014
+15%
|
649
-84%
|
332
-49%
|
230
-31%
|
231
+0%
|
233
+1%
|
232
0%
|
233
+0%
|
233
+0%
|
234
+0%
|
165
-29%
|
163
-1%
|
165
+1%
|
17
-90%
|
13
-24%
|
17
+28%
|
23
+37%
|
13
-44%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
557
|
|
| Retained Earnings |
597
|
597
|
597
|
597
|
838
|
836
|
403
|
399
|
396
|
388
|
387
|
385
|
384
|
354
|
224
|
101
|
127
|
141
|
143
|
|
| Additional Paid In Capital |
550
|
70
|
434
|
434
|
434
|
434
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1 704
N/A
|
1 223
-28%
|
1 588
+30%
|
1 588
N/A
|
153
-90%
|
155
+1%
|
154
-1%
|
157
+2%
|
161
+2%
|
169
+5%
|
169
+0%
|
172
+1%
|
173
+1%
|
202
+17%
|
333
+65%
|
456
+37%
|
684
+50%
|
697
+2%
|
699
+0%
|
|
| Total Liabilities & Equity |
5 192
N/A
|
5 238
+1%
|
2 237
-57%
|
1 920
-14%
|
383
-80%
|
385
+1%
|
387
+0%
|
390
+1%
|
394
+1%
|
402
+2%
|
403
+0%
|
337
-17%
|
336
0%
|
367
+9%
|
350
-5%
|
469
+34%
|
701
+49%
|
720
+3%
|
712
-1%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
56
|
|